45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,557
Insurances with rates
12
CPT / HCPCS codes
2,077
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1303 | ULTOMIRIS 1100MG/11ML | $143,680 | $86,208 | — | — | 17 |
| J9309 | POLIVY 140 MG VIAL | $117,522 | $70,513 | — | — | 17 |
| J2507 | KRYSTEXXA 8MG/ML INJECTION | $113,483 | $68,090 | — | — | 17 |
| J2350 | OCREVUS 300MG/10ML INJECTION | $90,295 | $54,177 | — | — | 17 |
| J9333 | RYSTIGGO 560 MG/4 ML VIAL | $80,465 | $48,279 | — | — | 17 |
| J2329 | BRIUMVI 150 MG VIAL | $70,156 | $42,094 | — | — | 17 |
| J2327 | SKYRIZI 600MG/10ML | $61,647 | $36,988 | — | — | 17 |
| J1440 | REBYOTA 150ML | $60,291 | $36,175 | — | — | 17 |
| J0896 | REBLOZYL 75MG VIAL | $60,210 | $36,126 | — | — | 17 |
| C1882 | ICD BI VENT QUADRA CD3369-40Q. | $57,124 | $34,275 | — | — | 7 |
| C1767 | GENERATOR IMPLANTABLE PULSE | $53,582 | $32,149 | — | — | 7 |
| C1721 | DEFIB CARDIAC MOMENTUM EL | $51,773 | $31,064 | — | — | 7 |
| J9022 | ATEZOLIZUMAB 1200MG/20ML INJ | $49,346 | $29,608 | — | — | 17 |
| J2997 | ACTIVASE 10MG/ML REPACKAGED | $48,901 | $29,341 | — | — | 17 |
| C1722 | DEFIB ELLIPSE DUAL 51X70 | $48,538 | $29,123 | — | — | 7 |
| J9144 | DARZALEX FASPRO | $44,174 | $26,504 | — | — | 17 |
| 36906 | PERQ THROMBO DIALY CIRC | $43,664 | $26,198 | — | — | 18 |
| J1930 | SOMATULINE DEPOT 120MG/0.5ML S | $40,281 | $24,169 | — | — | 17 |
| J9228 | YERVOY 5MG/ML INJ 10ML | $39,863 | $23,918 | — | — | 17 |
| J9042 | ADCETRIS 50MG/10ML INJ 0.2ML | $39,442 | $23,665 | — | — | 17 |
| C9773 | REVASC LITHOTR-STENT TIB/PER | $39,052 | $23,431 | — | — | 16 |
| J9223 | ZEPZELCA 4 MG VIAL | $38,687 | $23,212 | — | — | 17 |
| J7213 | IXINITY 3000 UNIT VIAL | $38,392 | $23,035 | — | — | 17 |
| J9332 | VYVGART 400MG/20ML | $38,245 | $22,947 | — | — | 17 |
| 0795T | TCAT INS 2CHMBR LDLS PM CMPL | $38,142 | $22,885 | — | — | 16 |
| 0796T | TCAT INS 2CHMBR LDLS PM RA | $38,142 | $22,885 | — | — | 16 |
| 0797T | TCAT INS 2CHMBR LDLS PM RV | $38,142 | $22,885 | — | — | 16 |
| 0801T | TCAT RMV&RPL 2CHMBR LDLS PM | $38,142 | $22,885 | — | — | 16 |
| 0802T | TCAT RMV&RPL2CHMB LDLS PM RA | $38,142 | $22,885 | — | — | 16 |
| 0803T | TCAT RMV&RPL2CHMB LDLS PM RV | $38,142 | $22,885 | — | — | 16 |
| J9311 | RITUXAN HYC 1400MG/11.7ML | $36,545 | $21,927 | — | — | 17 |
| J3101 | TNKASE 50MG INJ | $35,210 | $21,126 | — | — | 17 |
| J2802 | ROMIPLOSTIM 500 MCG INJ | $34,872 | $20,923 | — | — | 17 |
| 37241 | VASC OCCLUSION VENOUS | $34,237 | $20,542 | — | — | 17 |
| J3380 | VEDOLIZUMAB 300MG/5ML VIAL | $33,883 | $20,330 | — | — | 17 |
| J7169 | ANDEXXA 200MG VIAL | $33,655 | $20,193 | — | — | 16 |
| J2506 | NEULASTA 6MG 0.6ML INJECTION | $33,007 | $19,804 | — | — | 17 |
| C9600 | PRC DES+PLST 1 VSL LC | $30,962 | $18,577 | — | — | 16 |
| C9601 | PERC DES+PLSTY ADD LC | $30,962 | $18,577 | — | — | 6 |
| C9604 | REV BP GRF W/DES LD | $30,962 | $18,577 | — | — | 16 |
| C9605 | REV BP GRF W/DES LC | $30,962 | $18,577 | — | — | 6 |
| C9606 | REV MI W/DES 1 VSL LC | $30,962 | $18,577 | — | — | 6 |
| 37238 | TRNSCTH STENT INIT VEIN | $30,746 | $18,448 | — | — | 19 |
| A2025 | MIRO3D 100 CM3/CM3 | $30,557 | $18,334 | — | — | 6 |
| J2406 | KIMYRSA 1200MG VIAL | $29,886 | $17,932 | — | — | 17 |
| 37237 | TRNSCTH STENT ADDL ART | $29,607 | $17,764 | — | — | 6 |
| 93459 | LT HEART CATH LV+BP GRF | $29,417 | $17,650 | — | — | 18 |
| Q5108 | FULPHILA 6MG/0.6ML | $28,171 | $16,903 | — | — | 17 |
| 93460 | COMBINED LT AND RT HEART LV | $27,873 | $16,724 | — | — | 18 |
| 93461 | LT+RT HEART CATH+BP GRF | $27,873 | $16,724 | — | — | 16 |
Showing top 50 of 3,557 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.